These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20596091)

  • 1. A fully replication-competent adenovirus vector with enhanced oncolytic properties.
    Toth K; Kuppuswamy M; Shashkova EV; Spencer JF; Wold WS
    Cancer Gene Ther; 2010 Nov; 17(11):761-70. PubMed ID: 20596091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamsters.
    Dhar D; Spencer JF; Toth K; Wold WS
    J Virol; 2009 Mar; 83(5):2130-9. PubMed ID: 19073718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein.
    Toth K; Tarakanova V; Doronin K; Ward P; Kuppuswamy M; Locke JE; Dawson JE; Kim HJ; Wold WS
    Cancer Gene Ther; 2003 Mar; 10(3):193-200. PubMed ID: 12637940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector.
    Lichtenstein DL; Spencer JF; Doronin K; Patra D; Meyer JM; Shashkova EV; Kuppuswamy M; Dhar D; Thomas MA; Tollefson AE; Zumstein LA; Wold WS; Toth K
    Cancer Gene Ther; 2009 Aug; 16(8):644-54. PubMed ID: 19197324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies.
    Ying B; Toth K; Spencer JF; Meyer J; Tollefson AE; Patra D; Dhar D; Shashkova EV; Kuppuswamy M; Doronin K; Thomas MA; Zumstein LA; Wold WS; Lichtenstein DL
    Cancer Gene Ther; 2009 Aug; 16(8):625-37. PubMed ID: 19197322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus.
    Shashkova EV; Spencer JF; Wold WS; Doronin K
    Mol Ther; 2007 Mar; 15(3):598-607. PubMed ID: 17191072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein.
    Doronin K; Toth K; Kuppuswamy M; Ward P; Tollefson AE; Wold WS
    J Virol; 2000 Jul; 74(13):6147-55. PubMed ID: 10846098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.
    Spencer JF; Sagartz JE; Wold WS; Toth K
    Cancer Gene Ther; 2009 Dec; 16(12):912-22. PubMed ID: 19478829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers.
    Du T; Shi G; Li YM; Zhang JF; Tian HW; Wei YQ; Deng H; Yu DC
    Cancer Gene Ther; 2014 Aug; 21(8):340-8. PubMed ID: 25034886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model.
    Lei W; Liu HB; Wang SB; Zhou XM; Zheng SD; Guo KN; Ma BY; Xia YL; Tan WS; Liu XY; Wang YG
    Acta Pharmacol Sin; 2013 Apr; 34(4):531-40. PubMed ID: 23503473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter.
    Cheng PH; Rao XM; Duan X; Li XF; Egger ME; McMasters KM; Zhou HS
    J Mol Med (Berl); 2015 Feb; 93(2):211-23. PubMed ID: 25376708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
    Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
    Xiao LL; Wu YM; Qian J; Tan Y; Xie GL; Zhang KJ; Wang YG; Jia XY; Liu XY
    Cancer Biol Ther; 2010 Aug; 10(3):242-50. PubMed ID: 20574150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
    Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
    Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors.
    Young BA; Spencer JF; Ying B; Tollefson AE; Toth K; Wold WS
    Cancer Gene Ther; 2013 Sep; 20(9):521-30. PubMed ID: 23928731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cycles of transient high-dose cyclophosphamide administration and intratumoral oncolytic adenovirus vector injection for long-term tumor suppression in Syrian hamsters.
    Dhar D; Toth K; Wold WS
    Cancer Gene Ther; 2014 Apr; 21(4):171-8. PubMed ID: 24722357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.
    Doronin K; Kuppuswamy M; Toth K; Tollefson AE; Krajcsi P; Krougliak V; Wold WS
    J Virol; 2001 Apr; 75(7):3314-24. PubMed ID: 11238857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antitumor effect of combining TRAIL and MnSOD mediated by CEA-controlled oncolytic adenovirus in lung cancer.
    Zhang R; Zhang X; Ma B; Xiao B; Huang F; Huang P; Ying C; Liu T; Wang Y
    Cancer Gene Ther; 2016 Jun; 23(6):168-77. PubMed ID: 27080225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.